A bioanalytical company offering sample analysis in plasma, tissue samples and urine – fully compliant to OECD GLP and other relevant guidelines.
Our team consists of 8 dedicated analytical chemists who aim for fast and high-quality delivery of exactly what you need. We specialise in bioanalysis in the preclinical and clinical stage of your drug development.
Lablytica is part of the Swedish OECD GLP program. The last OECD GLP inspection of Lablytica was performed in November 2020.
Lablytica is regularly inspected by SWEDAC, the regulatory body performing OECD GLP inspection of laboratories in Sweden.